YU152587A - Monoklonska antitela i peptidi korisni u tretiranju i dijagnostifikovanju hiv-infekcija - Google Patents

Monoklonska antitela i peptidi korisni u tretiranju i dijagnostifikovanju hiv-infekcija

Info

Publication number
YU152587A
YU152587A YU152587A YU152587A YU152587A YU 152587 A YU152587 A YU 152587A YU 152587 A YU152587 A YU 152587A YU 152587 A YU152587 A YU 152587A YU 152587 A YU152587 A YU 152587A
Authority
YU
Yugoslavia
Prior art keywords
peptides
treatment
hiv
diagnosis
infections
Prior art date
Application number
YU152587A
Other languages
English (en)
Inventor
M.K. Shriver
Thomase
W.L. Cosand
L.H.. Gosting
E.S. Dickinson
J. Maclure
G.J. Todaro
R.C. Nowinski
Original Assignee
Genetics Systems Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Systems Corporation filed Critical Genetics Systems Corporation
Publication of YU152587A publication Critical patent/YU152587A/sh

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

MONOKLONSKA ANTITELA I PEPTIDI KORISNI U TRETIRANJU I DIJAGNOSTIFIKOVANJU HIV-INFEKCIJA. Pronalazak opisuje postupak za dobijanje peptida koji su sposobni da imunološki imitirju neutralizujuće epitope proteina iz HIV, nukleinsko-kiselinske probe koje kodiraju za takve peptide i monoklonska antitela koja su reaktivna sa takvim peptidima, kao i druge peptide koji utiču na infektivnost HIV. Ovi novi materijali nalaze primenu u, na primer, dijagnostičkim ispitivanjima za detekciju infekcije HIV i u terapijskim režimima za tretman takvih infekcija ili za vakcinaciju protiv njih.
YU152587A 1986-08-20 1987-08-17 Monoklonska antitela i peptidi korisni u tretiranju i dijagnostifikovanju hiv-infekcija YU152587A (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (1)

Publication Number Publication Date
YU152587A true YU152587A (sh) 1992-09-07

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
YU152587A YU152587A (sh) 1986-08-20 1987-08-17 Monoklonska antitela i peptidi korisni u tretiranju i dijagnostifikovanju hiv-infekcija

Country Status (28)

Country Link
JP (1) JPS6485928A (sh)
KR (1) KR920008744B1 (sh)
AT (1) AT398080B (sh)
AU (1) AU616156B2 (sh)
BE (1) BE1000811A4 (sh)
CH (1) CH675728A5 (sh)
CS (1) CS275838B6 (sh)
DE (1) DE3727703A1 (sh)
DK (1) DK433087A (sh)
ES (1) ES2010727A6 (sh)
FI (1) FI873553A (sh)
FR (1) FR2603107B1 (sh)
GB (1) GB2196634B (sh)
GR (1) GR871298B (sh)
HU (1) HU214439B (sh)
IE (1) IE60671B1 (sh)
IL (1) IL83580A (sh)
IT (1) IT1222518B (sh)
LU (1) LU86972A1 (sh)
NL (1) NL8701950A (sh)
NO (2) NO300462B1 (sh)
NZ (1) NZ221440A (sh)
OA (1) OA08652A (sh)
PL (1) PL155084B1 (sh)
PT (1) PT85567B (sh)
SE (1) SE506025C2 (sh)
YU (1) YU152587A (sh)
ZW (1) ZW15487A1 (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
EP0366718B1 (en) * 1987-05-29 1995-05-10 Tanox Biosystems, Inc. Monoclonal antibodies neutralizing hiv-1
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
JP2569185B2 (ja) * 1988-01-26 1997-01-08 アメリカ合衆国 抗ｈｉｖ応答を喚起する合成抗原
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
DK0960886T3 (da) * 1992-03-27 2004-09-27 Advanced Immuni T Inc Peptid T og beslægtede peptider til behandling af inflammation, herunder multipel sklerose
DK2783697T3 (en) * 2005-12-09 2017-04-10 Vectus Biosystems Ltd VIP Fragments and uses thereof
KR101215215B1 (ko) 2008-09-02 2012-12-24 니혼도꾸슈도교 가부시키가이샤 스파크 플러그

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
ATE86636T1 (de) * 1984-10-18 1993-03-15 Pasteur Institut F antigene vom menschlichen immunodefizienz-virus und deren verwendungen.
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
ATE109512T1 (de) * 1985-04-08 1994-08-15 Genetic Systems Corp Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
EP0220273B2 (en) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetic antigens for the detection of aids-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
ATE108022T1 (de) * 1985-10-24 1994-07-15 Southwest Found Biomed Res Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

Also Published As

Publication number Publication date
HU214439B (hu) 1998-03-30
OA08652A (fr) 1988-11-30
AT398080B (de) 1994-09-26
DK433087D0 (da) 1987-08-19
CH675728A5 (sh) 1990-10-31
CS275838B6 (en) 1992-03-18
FR2603107B1 (fr) 1992-04-24
ES2010727A6 (es) 1989-12-01
GR871298B (en) 1988-01-12
FI873553A (fi) 1988-02-21
GB8719587D0 (en) 1987-09-23
NO934897L (no) 1993-12-29
NO302176B1 (no) 1998-02-02
DK433087A (da) 1988-02-21
ZW15487A1 (en) 1988-09-14
HUT44619A (en) 1988-03-28
FR2603107A1 (fr) 1988-02-26
LU86972A1 (fr) 1988-03-02
IT8721678A0 (it) 1987-08-19
IL83580A0 (en) 1988-01-31
CS8706136A2 (en) 1990-08-14
JPS6485928A (en) 1989-03-30
KR920008744B1 (ko) 1992-10-09
BE1000811A4 (fr) 1989-04-11
PL267401A1 (en) 1988-07-21
AU616156B2 (en) 1991-10-24
KR890002547A (ko) 1989-04-10
SE8703225L (sv) 1988-02-21
NZ221440A (en) 1991-11-26
GB2196634A (en) 1988-05-05
IE60671B1 (en) 1994-08-10
ATA208987A (de) 1994-01-15
NO300462B1 (no) 1997-06-02
NO873495L (no) 1988-02-22
IT1222518B (it) 1990-09-05
PT85567B (pt) 1991-02-08
IL83580A (en) 1992-11-15
DE3727703A1 (de) 1988-05-05
NO934897D0 (no) 1993-12-29
PT85567A (en) 1987-09-01
SE506025C2 (sv) 1997-11-03
NL8701950A (nl) 1988-03-16
IE872219L (en) 1988-02-20
NO873495D0 (no) 1987-08-19
FI873553A0 (fi) 1987-08-17
AU7720187A (en) 1988-05-19
GB2196634B (en) 1991-05-15
PL155084B1 (en) 1991-10-31
SE8703225D0 (sv) 1987-08-19

Similar Documents

Publication Publication Date Title
YU152587A (sh) Monoklonska antitela i peptidi korisni u tretiranju i dijagnostifikovanju hiv-infekcija
Young et al. Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis
EP0214709B1 (en) Synthetic peptide and process of using same for the detection of antibodies to htlv-iii, diagnosis of aids and pre-aids conditions and as a vaccine
US4833071A (en) Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
KR960703136A (ko) 탠덤 합성 hiv-1 펩티드들
NZ219113A (en) Hiv peptide containing epitope of the env protein
HUP0002176A2 (hu) Vakcinákban vagy diagnosztikai vizsgálatokban alkalmazható PRRSV-peptidszekvenciákat azonosító PRRSV-antigénhelyek
Bartoloni et al. Mapping of a protective epitope of pertussis toxin by in vitro refolding of recombinant fragments
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
SE9102976L (sv) Hybrid dna vektorer, encelliga organismer och bakterier till anvaendning foer produktion av hiv-proteiner och peptider
DK0612250T3 (da) Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener
ATE238065T1 (de) Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
DK0469045T3 (da) Syntetiske Pseudomonas aeruginosa pilinpeptider og beslægtede vacciner diagnostica
ATE206620T1 (de) Menschliche, monoklonale antikörper gegen das transmembrane glycoprotein (gp41) des hiv-1, und verwandte peptide
DE3752131D1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
ES2071626T3 (es) Anticuerpo monoclonal de raton contra la proteina gp41 del virus de inmunodeficiencia humana.
ES2052370T3 (es) Peptidos o polipeptidos inmunologicamente activos del parvovirus b19.
FI854839A (fi) Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid.
JPH02500977A (ja) 新規ペプチド類及びその用途
DE69032009D1 (de) Peptide mit thiolgeschütztem cystein zur verwendung in immuntests
DE69017352D1 (de) An HIV relatierte Peptide.
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
Hunt et al. Mouse monoclonal antibody 5-21-3 recognizes a contiguous, conformation-dependent epitope and maps to a hydrophilic region in HIV-1 gp41
Qu et al. Checkerboard immunoblotting recognizes twenty epitopes among the B subunit proteins of the cholera enterotoxin family